Magnesium sulphate vs placebo: Hospital re‐admission within 30 days of discharge
Magnesium sulphate may leads to higher hospital re‐admission within 30 days of discharge (re‐admissions… compared with placebo (low certainty).
What each review found
Include earlier review versions| Finding | Effect | Studies | GRADE certainty |
|---|---|---|---|
Magnesium sulphate vs placebo Hospital re‐admission within 30 days of discharge (re‐admissions were reported at 14 days) · children up to 18 months old with acute bronchiolitis Magnesium sulphate may leads to higher hospital re‐admission within 30 days of discharge (re‐admissions… compared with placebo (low certainty). Magnesium sulphate for treating acute bronchiolitis in children up to two years of age (2020) · Cochrane Headline outcomes only | RR 3.16 [1.2, 8.27] | 1 study · 158 participants | Low |
Findings are shown side by side, never pooled across reviews.
The reviews
| Review | Searched up to | Included studies | AMSTAR 2 |
|---|---|---|---|
| Magnesium sulphate for treating acute bronchiolitis in children up to two years of age 2020 · Cochrane Headline outcomes only | Not reported | list not extracted yet | Not assessed |
Studies behind the findings
None of these reviews ties its included studies to this outcome in the data here. Cochrane reviews and reviews with headline outcomes only do not list their studies yet.
How reviews are matched to this question
Reviews word the same question differently. Four decision models (TypeSafe's Jev, Liquid AI's d1-ultra, SubQ Snap and Baseten's Elephant) judged each wording of the population, intervention, comparator and outcome against the others; two wordings count as the same when at least three of them agree and none clearly disagrees, and findings count as this question only when all four elements match. Timing, setting and subgroup never split a question: they are shown on each finding.